Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ESI is an Italian pharmaceutical and nutraceutical company specializing in the formulation, production, and marketing of herbal medicines, dietetic products, and food supplements. Founded in 1975, the company has established itself as a leader in the natural health sector, offering a wide range of products including the well-known Aloe Vera ESI line and various phytotherapeutic remedies. ESI operates with a strong focus on quality and scientific research, utilizing standardized extracts to ensure the efficacy of its natural formulations. The company's portfolio covers diverse therapeutic areas such as digestive health, immune support, and wellness, distributing products both domestically in Italy and internationally. In 2019, ESI was acquired by the Sodalis Group, further strengthening its position in the health and wellbeing market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ESI Pharma.